Randomized Phase II study comparing single agent oral vinorelbine administered with two different schedules in patients with Advanced Non Small Cell Lung Cancer unfit for a platinum-based chemotherapy
Randomized Phase II study comparing single agent oral vinorelbine administered with two different schedules in patients with Advanced Non Small Cell Lung Cancer unfit for a platinum-based chemotherapy
Randomized Phase II study comparing single agent oral vinorelbine administered with two different schedules in patients with Advanced Non Small Cell Lung Cancer unfit for a platinum-based chemotherapy
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Oncology
Disease :
Non small cell lung cancer (NSCLC)
Study medication :
Vinorelbine (Navelbine® Oral)
Phase :
Phase II
Start Date :
October 26, 2015
End date :
October 15, 2018
Study ID :
PM 0259 CA 232 J1
EudraCT/CTIS number :
2014-003859-61
Send by email